COMMUNIQUÉS West-GlobeNewswire

Navamedic ASA: Share option program
06/06/2018
On the basis of the approval by the Annual General Meeting of June 6 th 2017, to authorize the Board to issue 150 000 new shares to management under a long-term incentive program, the Board has now resolved to issue [...]
Avenue Therapeutics to Host Key Opinion Leader Call on Intravenous (IV) Tramadol for the Management of Postoperative Pain
06/06/2018
Neil Singla, M.D., Lotus Clinical Research, and Harold Minkowitz, M.D., HD Research Corporation, to participate in call on Monday, June 11, 2018, at 11 a.m. EDT NEW YORK, June 06, 2018 (GLOBE NEWSWIRE) -- Avenue [...]
Natus Annual Meeting - What’s at Stake?
06/06/2018
Natus Continues to Believe Voce’s Actions Indicate Its Desire to Take Control of the Natus Board, Fire the CEO and Halt Execution of the Company’s Successful Strategy The Natus Board Urges Shareholders to Vote the WHITE [...]
Terra Tech Corp. Begins IVXX Cultivation at New Sparks, Nevada Facility
06/06/2018
IRVINE, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp . (OTCQX:TRTC), a vertically integrated cannabis-focused agriculture company, is pleased to announce that it has commenced cultivation at its new Sparks [...]
Cesca Therapeutics Announces Exhibition at The Orthobiologic Institute’s 9th Annual PRP & Regenerative Medicine Symposium
06/06/2018
Company’s device subsidiary, ThermoGenesis, to exhibit its novel PXP™ cellular processing system at Booth 208 RANCHO CORDOVA, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or the “Company [...]
Daré Bioscience, Inc. Expands Leadership Team, Appointing David Friend, Ph.D. to Chief Scientific Officer
06/06/2018
SAN DIEGO, June 06, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a clinical-stage, women’s biopharmaceutical company, today announced the appointment of David Friend, Ph.D., to the newly created role of [...]
FDA Grants Rare Pediatric Disease Designation to Cellectar Biosciences’ CLR 131 for the Treatment of Rhabdomyosarcoma
06/06/2018
MADISON, Wis., June 06, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of [...]
Vedantra Pharmaceuticals Names Gregory I. Berk President and Chief Medical Officer
06/06/2018
CAMBRIDGE, Mass., June 06, 2018 (GLOBE NEWSWIRE) -- Vedantra Pharmaceuticals, Inc., an immunotherapy company focused on developing products to treat cancer and infectious disease, today announced the appointment of [...]
Article in Alzheimer's & Dementia Points to an Additional Unmet Medical Need Targeted by IntelGenx’ Montelukast VersaFilm™
06/06/2018
SAINT LAURENT, Quebec, June 06, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “Company” or “IntelGenx”) today announced that a peer-reviewed paper entitled “2018 Alzheimer’s Disease Facts and [...]
Biotricity’s Bioflux Named Best Remote Patient Monitoring Solution by MedTech Breakthrough
06/06/2018
Medical Device Innovator Honored for Innovation and For Exemplifying the Best in Healthcare Technology Solutions REDWOOD CITY, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB : BTCY), a medical [...]
GenMark Diagnostics to Present at the William Blair 38th Annual Growth Stock Conference
06/06/2018
CARLSBAD, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that President and Chief [...]
iCAD Named 2018 MedTech Breakthrough Award Winner
06/06/2018
Company’s PowerLook® Tomo Detection Solution Recognized as “Best New Radiology Solution” NASHUA, N.H., June 06, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD), a global medical technology leader providing innovative [...]
Laurie Heilmann Named President of New CrownBio Global Life Science and Diagnostic Solutions Division
06/06/2018
SAN DIEGO, June 06, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic [...]
Precipio Strengthens Patent Portfolio with Expanded Kit Claims for its Liquid Biopsy Enabling DNA Mutation Enrichment Technology
06/06/2018
NEW HAVEN, Conn., June 06, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), today announced the award of US patent No. 9,957,556 entitled FULL COLD-PCR ENRICHMENT WITH [...]
Matinas BioPharma to Present Preclinical Data at ASM Microbe 2018 Further Demonstrating the Broad Utility of its LNC Platform
06/06/2018
Data demonstrate safe, effective oral delivery of antimicrobial drugs utilizing LNC technology BEDMINSTER, N.J., June 06, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER:MTNB), a clinical-stage [...]
Strongbridge Biopharma plc to Present at the JMP Securities Life Sciences Conference
06/06/2018
DUBLIN, Ireland and TREVOSE, Pa., June 06, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
eFFECTOR Initiates Dosing of eFT508 in Phase 2 Expansion of Clinical Trial in Aggressive Form of Non-Hodgkin’s Lymphoma
06/06/2018
SAN DIEGO, June 06, 2018 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulators (STRs) for the treatment of cancer, today announced that it has dosed the first [...]
Metacrine Completes $65 Million Series C Financing
06/06/2018
Proceeds will support clinical development of FXR program in NASH and GI diseases SAN DIEGO, June 06, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., an innovative biotechnology company developing therapies to benefit [...]
Crescendo Bioscience Announces Four Studies with Vectra® DA Will Be Featured at the 2018 European League Against Rheumatism Annual Meeting
06/06/2018
SALT LAKE CITY, June 06, 2018 (GLOBE NEWSWIRE) -- Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ:MYGN), today announced that data on the use of the Vectra ® DA test will be presented at [...]

Pages